According to Gland Pharma 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.71. At the end of 2025 the company had a P/S ratio of 4.62.
Year | P/S ratio | Change |
---|---|---|
2025 | 4.62 | -10.15% |
2024 | 5.15 | -20.39% |
2023 | 6.46 | 1.62% |
2022 | 6.36 | -58.29% |
2021 | 15.2 | 23.54% |
2020 | 12.3 |